nVerses Capital’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,696
Closed -$42.6K – 228
2026
Q2
$42.6K Buy
+10,696
New +$29.4K 0.07% 278

Other funds holding TMCI

nVerses Capital's TMCI Position: Q3 2026 in Review

nVerses Capital sold out of Treace Medical Concepts (TMCI) in Q3 2026, closing a stake of 10,696 shares — an estimated $42.6K sold.

nVerses Capital first reported a position in TMCI in Q2 2026 and held it in 1 quarter. The position peaked at $42.6K in Q2 2026. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • nVerses Capital reported no remaining Treace Medical Concepts position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 10,696 Treace Medical Concepts shares in Q3 2026, an estimated $42.6K.
  • nVerses Capital first reported a position in Treace Medical Concepts in Q2 2026 and held it in 1 quarter.
  • nVerses Capital's Treace Medical Concepts position peaked at $42.6K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.